NCT03484260View on ClinicalTrials.gov

Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone

CompletedOBSERVATIONAL
Enrollment

27,778

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

May 15, 2018

Study Completion Date

May 15, 2018

Conditions
Hypogonadism
Interventions
DRUG

Testosterone Product

Men used testosterone product following prescription

Trial Locations (1)

13342

Many Locations, Berlin

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03484260 - Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone | Biotech Hunter | Biotech Hunter